Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB

Cells of the monocyte-macrophage lineage play a central role in the orchestration and resolution of inflammation. Plasticity is a hallmark of mononuclear phagocytes, and in response to environmental signals these cells undergo different forms of polarized activation, the extremes of which are called...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 106; no. 35; pp. 14978 - 14983
Main Authors Porta, Chiara, Rimoldi, Monica, Raes, Geert, Brys, Lea, Ghezzi, Pietro, Di Liberto, Diana, Dieli, Francesco, Ghisletti, Serena, Natoli, Gioacchino, De Baetselier, Patrick, Mantovani, Alberto, Sica, Antonio
Format Journal Article
LanguageEnglish
Published National Academy of Sciences 01.09.2009
National Acad Sciences
Subjects
Online AccessGet full text
ISSN0027-8424
1091-6490
DOI10.1073/pnas.0809784106

Cover

More Information
Summary:Cells of the monocyte-macrophage lineage play a central role in the orchestration and resolution of inflammation. Plasticity is a hallmark of mononuclear phagocytes, and in response to environmental signals these cells undergo different forms of polarized activation, the extremes of which are called classic or M1 and alternative or M2. NF-κB is a key regulator of inflammation and resolution, and its activation is subject to multiple levels of regulation, including inhibitory, which finely tune macrophage functions. Here we identify the p50 subunit of NF-κB as a key regulator of M2-driven inflammatory reactions in vitro and in vivo. p50 NF-κB inhibits NF-κB-driven, M1-polarizing, IFN-β production. Accordingly, p50-deficient mice show exacerbated M1-driven inflammation and defective capacity to mount allergy and helminth-driven M2-polarized inflammatory reactions. Thus, NF-κB p50 is a key component in the orchestration of M2-driven inflammatory reactions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by Michael Karin, University of California, San Diego School of Medicine, La Jolla, CA, and approved July 22, 2009
Author contributions: G.N., P.D.B., A.M., and A.S. designed research; C.P., M.R., G.R., L.B., P.G., D.D.L., F.D., and S.G. performed research; C.P. and A.S. analyzed data; and A.S. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0809784106